Research news

UCLH-led research paper outlines mechanism behind rare cases of blood clots and low platelets after vaccination

A study of patients at UCLH and North Middlesex University Hospital published in The Lancet Infectious Diseases suggests that the B.1.17. variant of Covid-19 is not associated with more severe illness and death, but appears to lead to higher virus load.

The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.

Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.

University College London Hospitals NHS Foundation Trust (UCLH) and Microsoft have announced a new strategic research and innovation collaboration to develop and apply advances in artificial intelligence (AI) and digital technologies for the future of healthcare delivery in the NHS.